Related Experiment Video
Updated: Jan 6, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Genetic differences between diagnosed and undiagnosed Celiac disease: a population-based study
Mohammad Sayeef Alam1,2, Brooke N Wolford3, Kristian Hveem3
1HUNT Center for Molecular and Clinical Epidemiology, NTNU, Norwegian University of Science and Technology, Trondheim, Norway. mohammad.s.alam@ntnu.no.
Many celiac disease (CeD) cases go undiagnosed, presenting with varied symptoms. A polygenic risk score (PRS) showed similar genetic risk in both known and newly diagnosed CeD individuals, suggesting non-genetic factors influence adult onset.
Area of Science:
- Genetics
- Gastroenterology
- Epidemiology
Background:
- Celiac disease (CeD) diagnosis is often delayed, with many individuals presenting later in life or with atypical symptoms.
- This diagnostic heterogeneity may stem from underlying genetic variations influencing disease presentation.
- Understanding genetic factors in both diagnosed and undiagnosed CeD populations is crucial for improving detection and management.
Purpose of the Study:
- To compare genetic variants, specifically using a polygenic risk score (PRS), between previously diagnosed CeD cases and newly identified cases within a screened adult population.
- To investigate the genetic architecture differences or similarities between known and newly diagnosed celiac disease individuals.
- To assess the predictive accuracy of a validated PRS in distinguishing CeD cases from the general population.
Main Methods:
- Utilized data from the Trøndelag Health Study (HUNT4), including 826 CeD cases (361 known, 465 new) and 51,516 non-CeD individuals.
- Applied a validated polygenic risk score (PRS) to evaluate genetic predisposition in CeD cases versus controls.
- Analyzed additional genetic variants beyond the PRS to identify potential associations with CeD.
Main Results:
- The PRS demonstrated high accuracy in distinguishing CeD cases (known and new) from non-cases (AUROC 85% and 83%, respectively).
- The PRS explained a comparable proportion of genetic variation in both known (17.1%) and new (14.5%) CeD cases.
- Individuals in the highest genetic risk group (top 10%) had significantly elevated odds of having CeD (OR 22.7 for known, 18.6 for new cases).
Conclusions:
- A validated PRS effectively identifies genetic differences between CeD cases and the general population.
- The genetic architecture appears similar between previously diagnosed and newly diagnosed CeD individuals.
- Non-genetic factors likely play a significant role in the heterogeneity of celiac disease presentation in adults.
More Related Videos
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...